Quick Answer
Emergent BioSolutions Inc. reported Operating Income of -$108.70 million for fiscal year 2024.
Emergent BioSolutions Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$108.70M | +85.0% |
| 2023 | -$726.40M | -327.3% |
| 2022 | -$170.00M | -149.8% |
| 2021 | $341.40M | -21.3% |
| 2020 | $433.80M | +280.2% |
| 2019 | $114.10M | +27.1% |
| 2018 | $89.80M | -27.8% |
| 2017 | $124.30M | +17.8% |
| 2016 | $105.50M | -25.4% |
| 2015 | $141.51M | +58.7% |
| 2014 | $89.19M | +108.4% |
| 2013 | $42.80M | +42.8% |
| 2012 | $29.97M | -6.6% |
| 2011 | $32.10M | -56.4% |
| 2010 | $73.56M | +83.2% |
| 2009 | $40.15M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $76.50M | +18.6% | +4681.2% |
| June 30, 2025 | $1.60M | +100.8% | -96.8% |
| March 31, 2025 | $49.90M | +25.4% | -22.6% |
| September 30, 2024 | $64.50M | +126.6% | +131.7% |
| June 30, 2024 | -$203.50M | +30.5% | -611.3% |
| March 31, 2024 | $39.80M | +127.0% | +116.4% |
| September 30, 2023 | -$242.10M | -434.4% | +17.3% |
| June 30, 2023 | -$292.90M | -283.9% | -98.4% |
- Emergent BioSolutions Inc. showed an increase of +85.0% in Operating Income compared to the prior fiscal year.
- Over the 2009–2024 period, Emergent BioSolutions Inc.’s operating income has declined by 370.7% (from $40.15 million to -$108.70 million).
- The most recent figure is from Emergent BioSolutions Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 4, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: